δ-Endorphin (bovine, camel, mouse, ovine)

DRUG PEPTIDES

Product Details

CAT No.# CS-AX-00063
Category Drug Peptides
CAS 66954-40-3
Molecular Weight 2996.48
Molecular Formula C136H215N35O39S
Purity: >98%
Synonyms: β-Endorphin (1-27) (bovine, camel, mouse, ovine), β-Lipotropin (61-87) (camel, ovine), β-Lipotropin (63-89) (bovine), β-Lipotropin (41-67) (mouse), Lipotropin Cī Fragment (camel) ; tyrosylglycylglycylphenylalanylmethionylthreonylseryl-α-glutamyllysylserylglutamylthreonylprolylleucylvalylthreonylleucylphenylalanyllysylasparagylalanylisoleucylisoleucyllysylasparagylalanylhistidine
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
δ-Endorphin (bovine, camel, mouse, ovine) Worldwide Suppliers of δ-Endorphin (bovine, camel, mouse, ovine) Drug Peptides Clearsynth CS-AX-00063

Product rating: 9 δ-Endorphin (bovine, camel, mouse, ovine) based on 20 ratings

  1. Drug Peptides
  2. δ-Endorphin (bovine, camel, mouse, ovine)

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B




This page contains information about δ-Endorphin (bovine, camel, mouse, ovine) Cas 66954-40-3 and its Drug Peptides.

δ-Endorphin (bovine, camel, mouse, ovine) δ-Endorphin (bovine, camel, mouse, ovine) Worldwide Suppliers of δ-Endorphin (bovine, camel, mouse, ovine) Drug Peptides Clearsynth 66954-40-3

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."